Development and validation of a multi-residue method for determination of 18 β-agonists in bovine urine by UPLC-MS/MS

Microchemical Journal

Volumn 115, Issue , 2014, Pages 70-77

  Mauro, D ^a   Ciardullo, S ^a   Civitareale, C ^a   Fiori, M ^a   Pastorelli, A A ^a   Stacchini, P ^a   Palleschi, G ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Bovine urine; Solid phase extraction; UPLC MS MS; Validation; agonists

Indexed keywords

EID: 84896386940     PISSN: 0026265X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.microc.2014.02.012     Document Type: Article

References (44)

1. Council of the European Union Council Regulation 1990/2377/EEC of 26 June 1990 laying down a community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin. Off. J. Eur. Communities 1990, L224:1-136.
2. Council of the European Union Commission Regulation 2010/37/EC of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin. Off. J. Eur. Communities 2010, L15:1-72.
3. Council of the European Union Council Directive 1996/22/EC of 29 April 1996 concerning the prohibition on the use in stockfarming of certain substances having a hormonal or thyrostatic action and of beta-agonists. Off. J. Eur. Communities 1996, L125:1-14.
4. Council of the European Union Council Directive 1996/23/EC of 29 April 1996 on measures to monitor certain substances and residues thereof in live animals and animal products. Off. J. Eur. Communities 1996, L125:10-32.
5. Martinez-Navarro J.F. Food poisoning related to consumption of illicit beta-agonist in liver. Lancet 1990, 336:1311.
6. Brambilla G., Loizzo A., Fontana L., Strozzi M., Guarino A., Soprano V. Food poisoning following consumption of clenbuterol-treated veal in Italy. J. Am. Med. Assoc. 1997, 278:635-640.
7. Sporano V., Grasso L., Esposito M., Oliviero G., Brambilla G., Loizzo A. Clenbuterol residues in non-liver containing meat as a cause of collective food poisoning. Vet. Hum. Toxicol. 1998, 40:141-143.
8. Brambilla G., Cenci T., Franconi F., Galarini R., Macri A., Rondoni F., Strozzi M., Loizzo A. Clinical and pharmacological profile in a clenbuterol epidemic poisoning of contaminated beef meat in Italy. Toxicol. Lett. 2000, 114:47-53.
9. Ramos F., Cristino A., Carrola P., Eloy T., Silva J.M., Castilho A.C., Noronha da Silveira M.I. Clenbuterol food poisoning diagnosis by gas chromatography-mass spectrometric serum analysis. Anal. Chim. Acta. 2003, 483:207-213.
10. Ricks C.A., Dalrymple R.H., Baker P.K., Ingle D.L. Use of a β-agonist to alter fat and muscle deposition in steers. J. Anim. Sci. 1984, 59:1247-1255.
11. Mersmann H.J. Overview of the effects of β-adrenergic receptor agonists on animal growth including mechanisms of action. J. Anim. Sci. 1998, 76:160-172.
12. 2-adrenergic agonists on rainbow trout muscle proteases and proteins. Comp. Biochem. Phys. A 2006, 144:145-154.
13. Angeletti R., Paleologo Oriundi M., Piro R., Bagnati R. Application of an enzyme-linked immunosorbent assay kit for β-agonist screening of bovine urines in north-eastern Italy. Anal. Chim. Acta. 1993, 275:215-219.
14. Haasnoot W., Streppel L., Cazemier G., Salden M., Stouten P., Essers M., van Wichen P. Development of a tube enzyme immunoassay for "on-site" screening of urine samples in the presence of beta-agonists. Analyst 1996, 121:1111-1114.
15. Delahaut P., Dubois M., Pri-Bar O., Buchman I., Degand G., Ectors F. Development of a specific radioimmunoassay for the detection of clenbuterol residues in treated cattle. Food Addit. Contam. 1991, 8:43-53.
16. Rashid B.A., Kwasowski P., Stevenson D. Solid phase extraction of clenbuterol from plasma using immunoaffinity followed by HPLC. J. Pharm. Biomed. Anal. 1999, 21:635-639.
17. Haasnoot W., Ploum M.E., Paulussen R.J., Schilt R., Huf F.A. Rapid determination of clenbuterol residues in urine by high-performance liquid chromatography with on-line automated sample processing using immunoaffinity chromatography. J. Chromatogr. 1990, 519:323-335.
18. Traynor I.M., Crooks S.R.H., Bowers J., Elliott C.T. Detection of multi-β-agonist residues in liver matrix by use of a surface plasma resonance biosensor. Anal. Chim. Acta. 2003, 483:187-191.
19. Degroodt J.M., Wyhowski de Bukanski B., De Groof J., Beernaert H. Cimaterol and clenbuterol residue analysis by HPLC-HPTLC in liver. Z. Lebensm. Unters. Forsch. 1991, 192:430-432.
20. 2-agonists in bovine urine: comparison of two extraction/clean-up procedures for high-resolution gas chromatography-mass spectrometry analysis. J. Anal. Toxicol. 2000, 24:146-152.
21. Council of the European Union Commission Decision 2002/657/EC of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Off. J. Eur. Communities 2002, L221:8-36.
22. Bernsmann T., Furst P., Godula M. Quick screening of priority beta-agonists in urine using automated TurboFlow™ LC/Exactive mass spectrometry. Food Addit. Contam. A 2011, 28:1352-1363.
23. Doerge D.R., Churchwell M.I., Holder C.L., Rowe L., Bajic S. Detection and confirmation of β-agonists in bovine retina using LC/APCI-MS. Anal. Chem. 1996, 68:1918-1923.
24. Hooijerink H., Schilt R., van Bennekom E.O., Huf F.A. Determination of beta sympathomimetics in liver and urine by immunoaffinity chromatography and gas chromatography-mass-selective detection. J. Chromatogr. B 1994, 660:303-313.
25. Bocca B., Fiori M., Cartoni C., Brambilla G. Simultaneous determination of Zilpaterol and other beta agonists in calf eye by gas chromatography/tandem mass spectrometry. J. AOAC Int. 2003, 86:8-14.
26. Sai F., Hong M., Yunfeng Z., Huijing C., Yongning W. Simultaneous detection of residues of 25 beta-agonists and 23 beta-blockers in animal foods by high-performance liquid chromatography coupled with linear ion trap mass spectrometry. J. Agric. Food Chem. 2012, 60:1898-1905.
27. Radeck W. Beta-agonists, anthelmintics, anticoccidials. EURL Workshop 2012: Technical, Analytical and Statistical Issues, Berlin, Germany 2012, 10.
28. Elliott C.T., Thompson C.S., Arts C.J.M., Crooks S.R.H., van Baak M.J., Verheij E.R., Baxter G.A. Screening and confirmatory determination of ractopamine residues in calves treated with growth promoting doses of the β-agonist. Analyst 1998, 123:1103-1107.
29. Williams L.D., Churchwell M.I., Doerge D.R. Multiresidue quantification and confirmation of beta-agonists in bovine retina and liver using LC-ES/MS/MS. J. Chromatogr. B 2004, 813:35-45.
30. Van Hoof N., Courtheyn D., Antignac J.P., Van de Wiele M., Poelmans S., Noppe H., De Brabander H. Multi-residue liquid chromatography/tandem mass spectrometric analysis of beta-agonists in urine using molecular imprinted polymers. Rapid Commun. Mass Sp. 2005, 19:2801-2808.
31. Blanca J., Muñoz P., Morgado M., Méndez N., Aranda A., Reuvers T., Hooghuis H. Determination of clenbuterol, ractopamine and zilpaterol in liver and urine by liquid chromatography tandem mass spectrometry. Anal. Chim. Acta. 2005, 529:199-205.
32. Nielen M.W.F., Lasaroms J.J.P., Essers M.L., Oosterink J.E., Meijer T., Sanders M.B., Zuidema T., Stolker A.A.M. Multiresidue analysis of beta-agonists in bovine and porcine urine, feed and hair using liquid chromatography electrospray ionisation tandem mass spectrometry. Anal. Bioanal. Chem. 2008, 391:199-210.
33. Shao B., Jia X., Zhang J., Meng J., Wu Y., Duan H., Tu X. Multi-residual analysis of 16 β-agonists in pig liver, kidney and muscle by ultra performance liquid chromatography tandem mass spectrometry. Food Chem. 2009, 114:1115-1121.
34. Churchwell M.I., Twaddle N.C., Meeker L.R., Doerge D.R. Improving LC-MS sensitivity through increases in chromatographic performance: comparisons of UPLC-ES/MS/MS to HPLC ES/MS/MS. J. Chromatogr. B 2005, 825:134-143.
35. 2-agonists in pork. Chromatographia 2010, 72:79-84.
36. Vulić A., Pleadina J., Perši N., Milić D., Radeck W. UPLC-MS/MS determination of ractopamine residues in retinal tissue of treated food-producing pigs. J. Chromatogr. B 2012, 895-896:102-107.
37. Jülicher B., Gowik P., Uhlig S. Assessment of detection methods in trace analysis by means of a statistically based in-house validation concept. Analyst 1998, 123:173-179.
38. Jülicher B., Gowik P., Uhlig S. A top-down in-house validation based approach for the investigation of the measurement uncertainty using fractional factorial experiments. Analyst 1999, 124:537-545.
39. InterValplus Software for In-house Validation 2012, quo data GmbH, Dresden, Germany, (http://www.quodata.de, accessed 7 November).
40. Document SANCO 2726/2004 rev.4 Guidelines for the Implementation of Decision 2002/657/EC http://ec.europa.eu/food/food/chemicalsafety/residues/cons_2004-2726rev4_en.pdf.
41. Smith D.J. The pharmacokinetics, metabolism, and tissue residues of beta-adrenergic agonists in livestock. J. Anim. Sci. 1998, 76:173-194.
42. n in horse doping control. Biomed. Chromatogr. 2011, 25:147-154.
43. León N., Roca M., Igualada C., Martins C.P.B., Pastor A., Yusá V. Wide-range screening of banned veterinary drugs in urine by ultra high liquid chromatography coupled to high-resolution mass spectrometry. J. Chromatogr. A 2012, 1258:55-65.
44. Du X.-D., Wu Y.-L., Yang H.-J., Yang T. Simultaneous determination of 10 _2-agonists in swine urine using liquid chromatography-tandem mass spectrometry and multi-walled carbon nanotubes as a reversed dispersive solid phase extraction sorbent. J. Chromatogr. A 2012, 1260:25-32.